[go: up one dir, main page]

EE200300566A - AMPA receptor allosteric positive naphthothiazine modulators - Google Patents

AMPA receptor allosteric positive naphthothiazine modulators

Info

Publication number
EE200300566A
EE200300566A EEP200300566A EEP200300566A EE200300566A EE 200300566 A EE200300566 A EE 200300566A EE P200300566 A EEP200300566 A EE P200300566A EE P200300566 A EEP200300566 A EE P200300566A EE 200300566 A EE200300566 A EE 200300566A
Authority
EE
Estonia
Prior art keywords
naphthothiazine
modulators
ampa receptor
receptor allosteric
allosteric positive
Prior art date
Application number
EEP200300566A
Other languages
Estonian (et)
Inventor
Ceci Angelo
Klinder Klaus
Weiser Thomas
Winter Karin
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of EE200300566A publication Critical patent/EE200300566A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
EEP200300566A 2001-05-17 2002-05-15 AMPA receptor allosteric positive naphthothiazine modulators EE200300566A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10123952A DE10123952A1 (en) 2001-05-17 2001-05-17 New naphtho-1,2-thiazine compounds, useful as neuroprotectants for treating e.g. epilepsy or Alzheimer's disease, are allosteric modulators of AMPA receptors
PCT/EP2002/005338 WO2002100411A1 (en) 2001-05-17 2002-05-15 Naphtothiazine positive allosteric ampa receptor modulators (paarm)

Publications (1)

Publication Number Publication Date
EE200300566A true EE200300566A (en) 2004-02-16

Family

ID=7685080

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300566A EE200300566A (en) 2001-05-17 2002-05-15 AMPA receptor allosteric positive naphthothiazine modulators

Country Status (26)

Country Link
EP (1) EP1404340A1 (en)
JP (1) JP2004529980A (en)
KR (1) KR20040007572A (en)
CN (1) CN1533278A (en)
AR (1) AR036332A1 (en)
BG (1) BG108324A (en)
BR (1) BR0209796A (en)
CA (1) CA2449189A1 (en)
CO (1) CO5550460A2 (en)
CZ (1) CZ20033112A3 (en)
DE (1) DE10123952A1 (en)
EA (1) EA006608B1 (en)
EC (1) ECSP034852A (en)
EE (1) EE200300566A (en)
HR (1) HRP20030933A2 (en)
HU (1) HUP0401273A3 (en)
IL (1) IL158642A0 (en)
MX (1) MXPA03010373A (en)
NO (1) NO20035088L (en)
NZ (1) NZ530154A (en)
PL (1) PL364053A1 (en)
SK (1) SK14222003A3 (en)
UY (1) UY27290A1 (en)
WO (1) WO2002100411A1 (en)
YU (1) YU90403A (en)
ZA (1) ZA200308466B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090047534A (en) * 2006-08-31 2009-05-12 더 거버너스 오브 더 유니버시티 오브 앨버타 Inhibition of respiratory depression using positive allosteric APMPA receptor modulators
CN111518058B (en) * 2020-05-29 2021-03-09 四川大学华西医院 Oxathiazine compound and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4345297A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
WO1999067242A1 (en) * 1998-06-25 1999-12-29 Merck & Co., Inc. Naphtho[1,8-de]thiasin-2-yl methyl carbapenem antibacterials
DE10004572A1 (en) * 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma New positive allosteric AMPA receptor modulators (PAARM), processes for their production and their use as medicines

Also Published As

Publication number Publication date
EA200301167A1 (en) 2004-06-24
AR036332A1 (en) 2004-09-01
BG108324A (en) 2004-12-30
NO20035088D0 (en) 2003-11-14
CA2449189A1 (en) 2002-12-19
CO5550460A2 (en) 2005-08-31
PL364053A1 (en) 2004-12-13
IL158642A0 (en) 2004-05-12
EA006608B1 (en) 2006-02-24
CZ20033112A3 (en) 2004-03-17
WO2002100411A1 (en) 2002-12-19
SK14222003A3 (en) 2004-05-04
EP1404340A1 (en) 2004-04-07
YU90403A (en) 2006-05-25
ECSP034852A (en) 2003-12-24
DE10123952A1 (en) 2002-11-21
JP2004529980A (en) 2004-09-30
HUP0401273A2 (en) 2004-10-28
KR20040007572A (en) 2004-01-24
ZA200308466B (en) 2004-05-24
HRP20030933A2 (en) 2004-04-30
MXPA03010373A (en) 2004-03-16
NO20035088L (en) 2003-11-14
UY27290A1 (en) 2002-12-31
HUP0401273A3 (en) 2006-11-28
NZ530154A (en) 2005-09-30
CN1533278A (en) 2004-09-29
BR0209796A (en) 2004-06-01

Similar Documents

Publication Publication Date Title
ATE293962T1 (en) ADENOSINE RECEPTOR MODULATORS
DK1446379T3 (en) Arylanilin-beta2-adrenergic receptor agonists
ATE544762T1 (en) CALCIUM RECEPTOR MODULATORS
NO20023663D0 (en) The bridge plug
DE60233024D1 (en) dry toner
AU2003290778A8 (en) Non-steroidal farnesoid x receptor modulators
IL158038A0 (en) Allosteric adenosine receptor modulators
DE60200539D1 (en) hinge
ATE459598T1 (en) SULFONAMIDE DERIVATIVES
NO20035183D0 (en) 5-substituted-2-arylpyridines as CRF1 modulators
DE50200230D1 (en) tripod
ATE374183T1 (en) NK1 ANTAGONISTS
DE60324919D1 (en) Viscous
DE50214751D1 (en) DOSING
DE60201256D1 (en) ELECTROOPTIC WAVEWAVE MODULATOR
DE50200210D1 (en) tripod
EE200300566A (en) AMPA receptor allosteric positive naphthothiazine modulators
EP1377281A4 (en) TAURINE COMPOUNDS
FR2831625B1 (en) TRIPOD TYPE HOMOCINETIC JOINT
ATA5002002A (en) VIBRATOR
DE50213194D1 (en) scraper
DE60232564D1 (en) fixing
ATA8202001A (en) drug applicator
DE60223671D1 (en) DOSING
DE50213685D1 (en) DOSING